End Cash: The amount of cash held by the company for the given period.
Gossamer Bio, Inc. (GOSS) had End Cash of $37.73M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$48.47M |
|
$-170.37M |
|
-- |
|
$48.47M |
|
$219.20M |
|
$-170.73M |
|
$0.27M |
|
$-170.46M |
|
$-170.46M |
|
$-170.37M |
|
$-170.37M |
|
$-170.37M |
|
$-170.37M |
|
$-170.73M |
|
$-176.02M |
|
228.52M |
|
228.52M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$167.64M |
|
$0.06M |
|
$4.61M |
|
$172.25M |
|
$63.44M |
|
$198.51M |
|
$231.57M |
|
$295.01M |
|
$-122.76M |
|
$-122.76M |
|
$-122.76M |
|
233.68M |
|
| Cash Flow Statement Financials | |
$-171.27M |
|
$156.36M |
|
$6.42M |
|
$46.07M |
|
|
End Cash |
$37.73M |
$-8.34M |
|
$10.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
2.62 |
|
-1.62 |
|
100.00% |
|
-352.23% |
|
-352.23% |
|
-363.14% |
|
-351.67% |
|
-351.49% |
|
$-171.34M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
3.96 |
|
92.07 |
|
138.78% |
|
138.78% |
|
-98.91% |
|
-224.92% |
|
$-0.53 |
|
$-0.75 |
|
$-0.75 |
|